0001484612-24-000047.txt : 20240517
0001484612-24-000047.hdr.sgml : 20240517
20240517173602
ACCESSION NUMBER: 0001484612-24-000047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240516
FILED AS OF DATE: 20240517
DATE AS OF CHANGE: 20240517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brottem John L.
CENTRAL INDEX KEY: 0001823381
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39513
FILM NUMBER: 24961548
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DR.
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outset Medical, Inc.
CENTRAL INDEX KEY: 0001484612
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 200514392
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 669-231-8200
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: Home Dialysis Plus, Ltd.
DATE OF NAME CHANGE: 20100219
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-05-16
0
0001484612
Outset Medical, Inc.
OM
0001823381
Brottem John L.
3052 ORCHARD DRIVE
SAN JOSE
CA
95134
0
1
0
0
General Counsel
0
Common Stock
2024-05-16
4
S
0
2972
3.53
D
243875
D
Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,887 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).
John L Brottem
2024-05-17